PALLAVI SHAMAPANT: Open Payments
NPI 1750062303 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,023 in 29 payments from 8 companies in 2025. Trend: 2023 $39 · 2024 $859 · 2025 $1,023
Food & beverage: $948Travel & lodging: $75
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 10 | $327 |
| AtriCure, Inc. | 3 | $256 |
| Abbott Laboratories | 6 | $208 |
| E.R. Squibb & Sons, L.L.C. | 4 | $70 |
| PFIZER INC. | 3 | $59 |
| AltaThera Pharmaceuticals LLC | 1 | $43 |
| Boston Scientific Corporation | 1 | $39 |
| Vital Connect, Inc | 1 | $21 |
Products named: EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, AFFERA MAPPING SYSTEM, GALLANT, ELIQUIS, Sotalol Hydrochloride, WATCHMAN FLX, VITALPATCH RTM, CAMZYOS.
Industry payments across TX — which companies pay providers there.
